AR090705A1 - PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K) - Google Patents
PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K)Info
- Publication number
- AR090705A1 AR090705A1 ARP130101238A AR090705A1 AR 090705 A1 AR090705 A1 AR 090705A1 AR P130101238 A ARP130101238 A AR P130101238A AR 090705 A1 AR090705 A1 AR 090705A1
- Authority
- AR
- Argentina
- Prior art keywords
- diseases
- inflammatory
- acute
- conditions
- treatment
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Heteroarilos bicíclicos sustituidos y composiciones que los contienen, ara el tratamiento de inflamación general, artritis, enfermedades reumáticas, osteoartritis, enfermedades inflamatorias intestinales, enfermedades inflamatorias oculares, enfermedades inflamatorias de la vejiga o vejiga inestable, psoriasis, afecciones de la piel con componentes inflamatorios, condiciones inflamatorias crónicas, incluyendo, pero sin limitarse a, enfermedades autoinmunes tales como lupus eritematoso sistémico (SLE), miastenia grave, artritis reumatoidea, encefalomielitis diseminada aguda, púrpura trombocitopénica idiopática, esclerosis múltiple, síndrome de Sjoegren y anemia hemolítica autoinmune, condiciones alérgica incluyendo todas las formas de hipersensibilidad. La presente también da a conocer métodos para el tratamiento de cánceres que son mediados por, dependen de, o están asociados con, la actividad p110d, incluyendo, pero sin limitarse a, leucemias tales como leucemia mieloide aguda (AML), síndrome mielodisplásico (MDS), enfermedades mieloproliferativas (MPD), leucemia mieloide crónica (CML), leucemia linfoblástica aguda de células T (T-ALL), leucemia linfoblástica aguda de células B (B-ALL), linfoma no Hodgkins (NHL), linfoma de células B y tumores sólidos, tales como el cáncer de mama. Reivindicación 1: Un compuesto seleccionado entre las fórmulas (1), (2), (3), (4), (5), (6) y (7), o cualquier sal farmacéuticamente aceptable del mismo.Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel diseases, inflammatory eye diseases, inflammatory diseases of the bladder or unstable bladder, psoriasis, skin conditions with inflammatory components, chronic inflammatory conditions, including, but not limited to, autoimmune diseases such as systemic lupus erythematosus (SLE), myasthenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiple sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions All forms of hypersensitivity. This also discloses methods for the treatment of cancers that are mediated by, depend on, or are associated with, p110d activity, including, but not limited to, leukemias such as acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) ), myeloproliferative diseases (MPD), chronic myeloid leukemia (CML), acute lymphoblastic T-cell leukemia (T-ALL), acute lymphoblastic B-cell leukemia (B-ALL), non-Hodgkins lymphoma (NHL), B-cell lymphoma and solid tumors, such as breast cancer. Claim 1: A compound selected from formulas (1), (2), (3), (4), (5), (6) and (7), or any pharmaceutically acceptable salt thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP130101238 AR090705A1 (en) | 2013-04-16 | 2013-04-16 | PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP130101238 AR090705A1 (en) | 2013-04-16 | 2013-04-16 | PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K) |
Publications (1)
Publication Number | Publication Date |
---|---|
AR090705A1 true AR090705A1 (en) | 2014-12-03 |
Family
ID=52145048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130101238 AR090705A1 (en) | 2013-04-16 | 2013-04-16 | PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K) |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR090705A1 (en) |
-
2013
- 2013-04-16 AR ARP130101238 patent/AR090705A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6630161A2 (en) | Heterocyclic compounds and their uses | |
EA201270013A1 (en) | HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION | |
MX2012015134A (en) | Heterocyclic compounds and their use as inhibitors of pi3k activity. | |
MX2013007261A (en) | Heterocyclic compounds and their uses. | |
AR077254A1 (en) | HETEROCICLICAL COMPOUNDS AND THEIR USES | |
MX2012015135A (en) | Heterocyclic compounds and their use as inhibitors of pi3k activity. | |
CY1117487T1 (en) | Heterocyclic compounds and their uses | |
MX2011013667A (en) | Heterocyclic compounds and their uses as inhibitors of pi3 k activity. | |
MX2009009968A (en) | Heterocyclic compounds and their uses. | |
MX2011013901A (en) | 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors. | |
CA2680853A1 (en) | 3- substituted quinoline or quinoxaline derivatives and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors | |
CA2680783A1 (en) | Heterocyclic compounds and their uses | |
MX2012015143A (en) | Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors. | |
MX2012015147A (en) | Heterocyclic compounds and their use as inhibitors of pi3k activity. | |
CL2013003073A1 (en) | Compounds derived from pyrrolotriazinone or imidazotriazinone, pi3k inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; Useful in the treatment of respiratory, inflammatory, autoimmune, neurological, cancer, among others. | |
CO2018006475A2 (en) | Compounds that inhibit eif4a and related methods | |
UY37854A (en) | DERIVATIVES OF 3- (1-OXOISOINDOLIN-2-IL) PIPERIDINA-2,6-DIONA AND USES OF THE SAME | |
AR104784A1 (en) | SHORT CHAIN PEPTIDES AS AGONISTS OF KAPPA (K) OR KOR OPIOID RECEIVERS | |
AR090705A1 (en) | PIRIDINE AND PYRIMIDINE COMPOUNDS AND THEIR USES AS 3-QUINASE PHOSPHYTIDYLINOSITOL INHIBITORS (PI3K) | |
MX2016014483A (en) | Novel compounds useful as s100-inhibitors. | |
CY1117196T1 (en) | Heterocyclic compounds and their uses | |
UY34748A (en) | HETEROCYCLIC COMPOUNDS AND THEIR USES | |
MX2019002166A (en) | Cxcr3 receptor agonists. | |
CY1114775T1 (en) | 3-Substituted Quinoline or Quinoxaline Derivative and Their Use as Phosphatidylinositol 3-Kinase Inhibitors (R3K) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |